Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Thrombosis Research|October 1, 1995
Pooled patient samples as reference material for D-DimerE Adema, U GebertArzneimittel-Forschung|January 1, 1978
Chemotherapeutically active nitro-derivatives. 4. 5-Nitroimidazoles (Part IV)E Winkelmann, W Raether, U GebertArzneimittel-Forschung|May 1, 1993
Effect of a novel xanthine derivative on experimental ulcers in ratsT Tanaka, Y Morioka, U GebertArzneimittel-Forschung|January 1, 1977
Chemotherapeutically active nitro compounds. 4. 5-Nitroimidazoles (Part I)E Winkelmann, W Raether, U Gebert, et al.International Journal of Immunopharmacology|January 1, 1991
Effect of the new immunostimulator HAB 439 on cell-mediated immunity against intracellular bacteriaG Dickneite, W Schwab, H U Schorlemmer, et al.European Journal of Endocrinology|October 3, 2001
Urinary aquaporin-2 excretion in nocturnal enuresisG Radetti, C Paganini, F Rigon, et al.Biotechnology and Bioengineering|January 20, 1989
Mathematical descriptions of hybridoma culture kinetics: II. The relationship between thiol chemistry and the degradation of serum activityM W Glacken, E Adema, A J SinskeyBiotechnology and Bioengineering|August 5, 1988
Mathematical descriptions of hybridoma culture kinetics: I. Initial metabolic ratesM W Glacken, E Adema, A J SinskeyDrugs Under Experimental and Clinical Research|January 1, 1989
Substituted 3-phenyl-7H-thiazolo(3,2-b)(1,2,4)triazin-7-ones as antiinflammatory agents with immunomodulating propertiesR R Bartlett, U Gebert, B Kerékjártó, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Epstein-Barr virus related hemophagocytic syndrome in a T-cell rich B-cell lymphomaM Mitterer, N Pescosta, C McQuain, et al.Pageof 2